Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Mineishi, Shin  [Clear All Filters]
2024
Guare EG, Hale CM, Sivik J, Lehman E, Inoue Y, Rakszawski K, Songdej N, Nickolich M, Zheng H, Naik S, et al. The addition of doxycycline to fluoroquinolones for bacterial prophylaxis in autologous stem cell transplantation for multiple myeloma. Transpl Infect Dis. 2024:e14241.
Brow D, Shike H, Kendrick J, Pettersson L, Mineishi S, Claxton DF, Wirk B, Cioccio J, Greiner RJ, Viswanatha D, et al. Assessment of chimerism by next generation sequencing: A comparison to STR/qPCR methods. Hum Immunol. 2024:110794.
Zhang A, Macecevic S, Thomas D, Allen J, Mandley S, Kawczak P, Jurcago R, Tyler J, Casey H, Bosler D, et al. Engraftment and Measurable Residual Disease Monitoring after Hematopoietic Stem Cell Transplantation - Comparison of Two Chimerism Test Strategies, Next-generation Sequencing vs. a Combination of Short Tandem Repeats and Quantitative PCR. J Mol Diagn. 2024.
2023
Jia B, Zhao C, Minagawa K, Shike H, Claxton DF, W Ehmann C, Rybka WB, Mineishi S, Wang M, Schell TD, et al. Acute Myeloid Leukemia Causes T Cell Exhaustion and Depletion in a Humanized Graft-versus-Leukemia Model. J Immunol. 2023.
Potiaumpai M, Schmitz KH, Mineishi S, Naik S, Wirk B, Rakszawski K, W Ehmann C, Claxton D, Nickolich M, Zemel BS, et al. IMPROVE-BMT: a protocol for a pilot randomised controlled trial of prehabilitation exercise for adult haematopoietic stem cell transplant recipients. BMJ Open. 2023;13(1):e066841.
2022
Cioccio J, Rakszawski K, Zheng H, Nickolich M, Naik S, Wirk B, Rybka W, Ehmann C, Silar B, Vajdic C, et al. Donor HLA mismatch promotes full donor T-cell chimerism in the allogeneic stem cell transplant with reduced-intensity conditioning and post-transplant cyclophosphamide GVHD prophylaxis. Ann Hematol. 2022.
Shah N, Cioccio J, Rakszawski K, Zheng H, Nickolich M, Naik S, Wirk B, Rybka W, Ehmann C, Silar B, et al. Low-dose total body irradiation promotes T-cells donor chimerism in reduced-intensity/non-myeloablative allogeneic stem cell transplant with post-transplant cyclophosphamide. Leuk Res. 2022;123:106969.
Jamy O, Arora S, Meredith R, Salzman D, Di Stasi A, Minagawa K, Mineishi S, Saad A. Phase II study of myeloablative allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia in adults using fludarabine and total body irradiation 12 Gy. Bone Marrow Transplant. 2022.
2020
Gvozdjan K, Casey H, Mowery C, Kumer L, Fisher C, Tyler J, Bayerl MG, Malysz J, Naik S, Rybka W, et al. Unexpected Short-Tandem-Repeat Patterns in Posttransplant Chimerism Testing: Investigation of 3 Cases with Help from Forensic Science. Lab Med. 2020.
2016
Pasquini MC, Le-Rademacher J, Zhu X, Artz A, DiPersio J, Fernandez H, Mineishi S, Kamishohara M, Mehta J, Nakamura Y, et al. Intravenous Busulfan-Based Myeloablative Conditioning Regimens Prior to Hematopoietic Cell Transplantation for Hematologic Malignancies. Biol Blood Marrow Transplant. 2016.
2015
Khan M, Ubogu E, Alsharabati M, Salzman D, Mineishi S, Saad A. Acute Myofascitis as a Manifestation of Chronic Graft Versus Host Disease. Muscle Nerve. 2015.
Meng L, Bai Z, He S, Mochizuki K, Liu Y, Purushe J, Sun H, Wang J, Yagita H, Mineishi S, et al. The Notch Ligand DLL4 Defines a Capability of Human Dendritic Cells in Regulating Th1 and Th17 Differentiation. J Immunol. 2015.
Jamil MOmer, Mineishi S. State-of-the-art acute and chronic GVHD treatment. Int J Hematol. 2015.
Saad A, Mineishi S, Innis-Shelton R. Telomere Length in Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia: Is It Ready for "Prime Time"?. JAMA. 2015;313(6):571-572.